ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: All components of the AURKA-PLK1-FOXM1 axis appear to be hyperactivated due to multiple events associated with a BCR-ABL fusion protein that promotes resistance to tyrosine kinase inhibitors in chronic myeloid leukemia (CML) (90–94).